Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122255479 | 12225547 | 9 | F | 20160320 | 20160725 | 20160331 | 20160727 | EXP | JP-PFIZER INC-2016180038 | PFIZER | 77.00 | YR | F | Y | 35.00000 | KG | 20160727 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122255479 | 12225547 | 1 | PS | TOFACITINIB CITRATE | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 1X/DAY | 10 | MG | Y | 203214 | 5 | MG | TABLET | QD | |||
| 122255479 | 12225547 | 2 | SS | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | UNK | Y | 11719 | CAPSULE | ||||||||
| 122255479 | 12225547 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | UNK | U | 21446 | CAPSULE, HARD | ||||||||
| 122255479 | 12225547 | 4 | SS | MYTELASE | AMBENONIUM CHLORIDE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 122255479 | 12225547 | 5 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | U | 0 | ORODISPERSIBLE TABLET | ||||||||
| 122255479 | 12225547 | 6 | C | NEUROTROPIN | NEUROTROPIN | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 7 | C | MENATETRENONE | MENATETRENONE | 1 | Oral | 0 | CAPSULE | ||||||||||
| 122255479 | 12225547 | 8 | C | POLAPREZINC | POLAPREZINC | 1 | Oral | 0 | GRANULES | ||||||||||
| 122255479 | 12225547 | 9 | C | FEBURIC | FEBUXOSTAT | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 10 | C | SODIUM FERROUS CITRATE | SODIUM FERROUS CITRATE | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 11 | C | TOYOFAROL | ALFACALCIDOL | 1 | Oral | 0 | CAPSULE | ||||||||||
| 122255479 | 12225547 | 12 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 13 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 14 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 0 | TABLET | ||||||||||
| 122255479 | 12225547 | 15 | C | SENNOSIDE | SENNOSIDES | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122255479 | 12225547 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122255479 | 12225547 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122255479 | 12225547 | Condition aggravated | |
| 122255479 | 12225547 | Cough | |
| 122255479 | 12225547 | Pancytopenia | |
| 122255479 | 12225547 | Platelet count decreased | |
| 122255479 | 12225547 | Pyrexia | |
| 122255479 | 12225547 | Rash | |
| 122255479 | 12225547 | Stomatitis | |
| 122255479 | 12225547 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122255479 | 12225547 | 1 | 20160319 | 20160322 | 0 | |
| 122255479 | 12225547 | 2 | 20160325 | 0 |